Summary
Randomized controlled clinical trials are the preferred scientific method and remain the vital bridge between basic science and improvements in health care according to general agreement. However, discussion has revealed various critical issues in the field of intraabdominal infection. Many of these critical points can be dealth with by prognostic scoring systems. In this paper the application areas for scores in clinical trials on intraabdominal infections are presented. These areas cover: assessment of severity of disease, definition of inclusion/exclusion criteria, analysis of comparability, adjustment for noncomparability, definition of end points and comparison of observed versus predicted outcome. The use of scoring systems in defining treatment policies is still experimental.
Similar content being viewed by others
References
Spodick, D. H.: Randomized controlled clinical trials. The behavioral case. JAMA 247 (1982) 2258–2260.
Beahrs, O. H.: Clinical trials from the surgeon’s view. Cancer 65 (1990) 2383–2384.
Discussion Forum: Methodology of clinical trial in sepsis. Theor. Surg. 9 (1994) 10–67.
Ohmann, C., Hau, T.: Prognostic indices in peritonitis. Hepato-gastroenterology 44 (1997) 937–946.
Ohmann, C., Yang, Q., Hau, T., Wacha, H. andthe Peritonitis Study Group of the Surgical Infection Society Europe: Prognostic modelling in peritonitis. Eur. J. Surg. 163 (1997) 53–60.
Gastinne, H., Wolff, M., Delatour, F., Faurisson, F., Chevet, S. andthe French Study Group on Selective Decontaminuation of the Digestive Tract: A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. N. Engl. J. Med. 326 (1992) 594–599.
Dominioni, L., Dionigi, R., Zanello, M., Chiarananda, M., Dionigi, R., Acquarolo, A., Ballabio, A., Sguotti, C.: Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater. Arch. Surg. 126 (1991) 236–240.
Hoogkamp-Korstanje, J. A. A.: Ciprofloxacin vs. cefotaxime regimens for the treatment of intraabdominal infections. Infection 28 (1995) 278–282.
Solomkin, J. S., Dellinger, E. P., Christou, N. V., Busuttil, R. W.: Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for anti-abdominal infections. Ann. Surg. 212 (1990) 581–591.
Wittmann, D. H., Bansal, N., Bergstein, J. M., Wallace, J. R., Wittmann, M. M., Aprahamian, C.: Staged abdominal repair compares favorably with conventional operative therapy for intra-abdominal infections when adjusting for prognostic factors with a logistic model. Theor. Surg. 9 (1994) 201–207.
Hau, T., Ohmann, C., Wolmershäuser, A., Wacha, H., Yang, Q. for the Peritonitis Study Group of the Surgical Infection Society Europe: Planned relaparotomy vs relaparotomy on demand in the treatment of intraabdominal infections. Arch. Surg. 130 (1995) 1193–1197.
Nyström, P. O., Bax, R., Dellinger, E. P., Dominioni, L., Knaus, W. A., Meakins, S. L., Ohmann, C., Solomkin, J. C., Wacha, H., Wittmann, D. H.: Proposed definitions for diagnosis, severity scoring, stratification and outcome for trials on intraabdominal infection. World J. Surg. 14 (1990) 148–158.
Pilz, G., Fateh-Moghadam, S., Viell, B., Bujdoso, O., Döring, G., Marget, W., Neumann, R., Werdan, K.: Supplement immunoglobin therapy in sepsis and septic shock—comparison of mortality under treatment with polyvalent i.v immunoglobin versus placebo. Protocol of a multicenter, randomized, prospective, double-blind trial. Theor. Surg. 8 (1993) 61–83.
Wittmann, D. H., Aprahamian, C., Bergstein, J. M.: Staged abdominal repair advanced diffuse peritonitis managed by planned multiple laparotomies utilizing zippers, slide fastener, and velcro analogue for temporary abdominal closure. World J. Surg. 14 (1990) 218–226.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohmann, C. Prognostic scores and design of clinical studies. Infection 26, 342–344 (1998). https://doi.org/10.1007/BF02962268
Issue Date:
DOI: https://doi.org/10.1007/BF02962268